Medicines and Healthcare products Regulatory Agency
Regulatory Agency
- Alerts, recalls and safety information: medicines and medical devices
- Drug Safety Update
- Yellow Card: Report a problem with a medicine or medical device
- Marketing authorisations and licensing guidance
- Product information about medicines
- Regulating medical devices
- Latest information for patients
- About MHRA
- All MHRA services and information
Featured
Press release
Four sentenced to nearly 15 years combined jail time following major MHRA investigation into illegal online supply of medicines
The MHRA’s Criminal Enforcement Unit dismantled a multimillion-pound criminal network responsible for illegally supplying medicines.
Press release
Nerandomilast (Jascayd) approved to treat adult patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
As with any medicinal product, the MHRA will keep the safety and effectiveness of nerandomilast under close review.
Press release
MHRA approves Retifanlimab (ZYNYZ) for the treatment of advanced Merkel cell skin cancer
Merkel cell carcinoma (MCC) is a rare and aggressive type of skin cancer that develops from Merkel cells, specialised neuroendocrine cells found in the top layer of the skin.
Press release
Semaglutide (Wegovy) approved to treat form of liver disease
The semaglutide injection has been approved to treat metabolic-associated steatohepatitis (MASH) in adults with moderate-to-advanced liver fibrosis.
News story
Making regulation a catalyst, not a barrier, for UK life sciences
MHRA CEO argues that for the UK’s long-term health and prosperity, regulation should help lead, rather than follow, innovation
News story
Don’t let this heatwave affect your medicines: Three important tips from the MHRA
Essential advice on protecting your medicines during extreme heat and staying safe.
Latest from the Medicines and Healthcare products Regulatory Agency
Subscriptions
What we do
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK.
MHRA is an executive agency, sponsored by the Department of Health and Social Care.
Follow us
Documents
Transparency and freedom of information releases
Our management
Contact MHRA
General enquiries
10 South Colonnade
London
E14 4PU
United Kingdom
Telephone
020 3080 6000
Fax
020 3118 9803
Office hours are Monday to Friday, 9am to 5pm.
Media enquiries
MHRA10 South Colonnade
London
E14 4PU
United Kingdom
Telephone (including out of hours):
020 3080 7651
Make a Freedom of Information (FOI) request
- Read about the Freedom of Information (FOI) Act and how to make a request.
- Check our previous releases to see if we’ve already answered your question.
- Make a new request by contacting us using the details below.
Freedom of Information
10 South Colonnade
London
E14 4PU
United Kingdom